Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1991-12-11
1994-03-15
Lee, Mary C.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
548507, A61K 3140, C07D20914
Patent
active
052946363
ABSTRACT:
A physical form of N-[4-[5 -(cyclopentyloxycarbonyl)amino-1-methyl-indol-3-ylmethyl]-3-methoxybenzoyl ]-2-methylbenzenesulphonamide substantially free of other physical forms, which form is crystalline, has an X-ray powder diffraction pattern with specific peaks occuring at 2.theta.=8.1, 13.7, 16.4, 20.5 and 23.7.degree. and an infra-red spectrum (0.5% in KBr) having sharp peaks at 3370, 1670, 1525, 1490, 1280, 890, 870 and 550 cm.sup.-1, a process for its preparation and pharmaceutical compositions containing it. Also disclosed is a flowable preparation of the physical form which is in the form of soft pellets, and a process for obtaining this preparation.
REFERENCES:
patent: 4161516 (1979-07-01), Bell
Edwards Martin P.
Sherwood John D.
Haley Jacqueline
Imperial Chemical Industries plc
Jackson Thomas E.
Lee Mary C.
LandOfFree
Crystalline form of indole derivative and pharmaceutical method does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Crystalline form of indole derivative and pharmaceutical method , we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Crystalline form of indole derivative and pharmaceutical method will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1536314